Ganciclovir-Resistant Cytomegalovirus (CMV) Retinitis in a Patient with Wild-Type CMV in Her Plasma

被引：6
|
作者：
Moss, Hart B. [2 ]
Chavala, Sai [2 ]
Say, Emil [2 ]
Miller, Melissa B. [1 ]
机构：
[1] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 05期
关键词：
POLYMERASE-CHAIN-REACTION; DRUG-RESISTANCE; DNA; MUTATIONS; DIAGNOSIS;
D O I：
10.1128/JCM.00029-12
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A patient with systemic cytomegalovirus (CMV), including chorioretinitis, received localized and systemic ganciclovir, systemic cidofovir analog, and localized foscarnet. Mutations conferring ganciclovir and cidofovir resistance were detected in CMV from the aqueous fluid but not in CMV from plasma. Quantifying CMV from aqueous fluid was valuable for monitoring the clinical response and predicting resistance.
引用
收藏
页码：1796 / 1799
页数：4
相关论文
共 50 条
  • [31] Ganciclovir-Resistant Cytomegalovirus (GCV-R CMV) Infection in Solid Organ Transplant (SOT) Recipients: A Single Center Experience
    Gilligan, P.
    Angarone, M.
    Flaherty, J.
    Penugonda, S.
    Stosor, V.
    Ison, M. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 474 - 474
  • [32] Mutations in the CMV UL97 gene associated with ganciclovir resistant retinitis
    Margolis, TP
    Liu, W
    Kuppermann, BD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 3071 - 3071
  • [33] Progressive retinitis-encephalitis due to ganciclovir-resistant cytomegalovirus associated with aplastic anemia
    Sasaki, T
    Okayama, A
    Eizuru, Y
    Murai, K
    Matsuoka, H
    Uno, H
    Minamishima, Y
    Kataoka, H
    Koono, M
    Matsuura, Y
    NaoI, N
    Sawada, A
    Tachibana, N
    Tsubouchi, H
    INTERNAL MEDICINE, 1997, 36 (05) : 375 - 379
  • [34] Design of clinical trials for drug combinations: Cytomegalovirus retinitis - Foscarnet and ganciclovir. The CMV retinitis retreatment trial
    Jabs, DA
    ANTIVIRAL RESEARCH, 1996, 29 (01) : 69 - 71
  • [35] Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
    Holmes-Liew, Chien-Li
    Holmes, Mark
    Beagley, Leone
    Hopkins, Peter
    Chambers, Daniel
    Smith, Corey
    Khanna, Rajiv
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2015, 4
  • [36] Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis
    Piketty, C
    Bardin, C
    Gilquin, J
    Gairard, A
    Kazatchkine, MD
    Chast, F
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (03) : 117 - 120
  • [37] FAILURE OF HIGH-DOSE ORAL ACYCLOVIR TO SUPPRESS CMV VIRURIA OR INDUCE GANCICLOVIR-RESISTANT CMV IN HIV ANTIBODY-POSITIVE PATIENTS
    DREW, WL
    ANDERSON, R
    LANG, W
    MINER, RC
    DAVIS, G
    LALEZARI, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (03): : 289 - 291
  • [38] Suspected Retinal Toxicity After Multiple Intravitreal Ganciclovir Injections in a Patient of CMV Retinitis
    Kapoor, Rohan
    Sadda, SriniVas
    Tyagi, Mudit
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (05) : 525 - 528
  • [39] ADOPTIVE T-CELL IMMUNOTHERAPY FOR TREATMENT OF GANCICLOVIR-RESISTANT CMV DISEASE AFTER LUNG TRANSPLANTATION
    Holmes-Liew, C.
    Holmes, M.
    Beagley, L.
    Hopkins, P.
    Chambers, D.
    Smith, C.
    Khanna, R.
    RESPIROLOGY, 2015, 20 : 117 - 117
  • [40] Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia.
    Fose, J.
    Jorgenson, M.
    Degrave, Z.
    Redfield, R.
    Smith, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 532 - 532
12345